FindTrial
Sign In

Mencevax ACWY

BIOLOGICAL5 trials

Sponsors

GlaxoSmithKline

Conditions

DiphtheriaDiphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis VaccinHaemophilus Influenzae Type bHepatitis BInfections, MeningococcalTetanusWhole Cell Pertussis

Phase 2

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine
CompletedNCT00126984
GlaxoSmithKlineInfections, Meningococcal
Start: 2005-07-31End: 2008-02-29Updated: 2016-10-07

Phase 3

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m
CompletedNCT00136604
GlaxoSmithKlineDiphtheria, Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin, Haemophilus Influenzae Type b +3
Start: 2006-01-22End: 2006-04-23Updated: 2020-02-20
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds
CompletedNCT01154088
GlaxoSmithKlineInfections, Meningococcal
Start: 2010-08-27End: 2010-12-30Updated: 2018-11-26

Phase 4

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs
CompletedNCT00227422
GlaxoSmithKlineInfections, Meningococcal
Start: 2005-06-30End: 2005-11-30Target: 324Updated: 2016-09-21
Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years
CompletedNCT00290329
GlaxoSmithKlineInfections, Meningococcal
Start: 2006-01-14End: 2006-10-17Updated: 2018-06-08

Related Papers

Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children.
2012-04-0920 citations